Lung Cancer Clinical Trials in Amsterdam, North Holland
4 recruitingAmsterdam, North Holland, Netherlands
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Extensive-stage Small-cell Lung Cancer
Bristol-Myers Squibb530 enrolled184 locationsNCT06646276
Recruiting
Phase 2Phase 3
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Non-small Cell Lung Cancer
Bristol-Myers Squibb596 enrolled185 locationsNCT07100080
Recruiting
Phase 2
Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
Non-Small-Cell Lung CarcinomaEGFR Gene MutationAdvanced Non-Small Cell Squamous Lung Cancer
The Netherlands Cancer Institute16 enrolled1 locationNCT06222489
Recruiting
Phase 4
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
Lung CancerCarcinoma, Non-Small Cell LungDrug Monitoring+2 more
University Medical Center Groningen196 enrolled8 locationsNCT05525338